biotech.today

Details

  • ●Modalities: small molecules
  • ●Therapeutic areas: oncology, infectious disease
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $123M

Partners & investors

  • Bayer· Investor
  • Eli Lilly· Investor
  • Merck· Investor
  • Sanofi· Investor

Key considerations

  • ●AI tools in use: AtomNet
  • ●$123M Series B (2020)
  • ●750+ academic partnerships (AIMS program)
  • ●Eli Lilly, Bayer, Sanofi, Merck, Bridge Bio partnerships
Get live updates on Atomwise’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Abraham Heifets

Co-Founder & CEO

structure-based-drug-discovery
Visit website →LinkedIn →